Avian Necrosis and Clostridial Enteritis in Chickens: Etiology, Pathogenesis, Diagnosis, and Control

Introduction

Clostridial enteritis represents a major disease complex in commercial poultry production, particularly in broiler chickens. The condition encompasses two primary entities: necrotic enteritis (NE) caused by Clostridium perfringens and ulcerative enteritis (UE) caused by Clostridium colinum [1, 2]. These diseases are characterized by intestinal necrosis, increased flock morbidity and mortality, and substantial economic losses due to reduced weight gain and feed efficiency [3, 4]. The global intensification of poultry production and the concurrent reduction in the use of antibiotic growth promoters have heightened the clinical relevance of these infections [5, 6]. This article provides a detailed review of the etiology, epidemiology, clinical signs, pathology, diagnostics, treatment, and control of avian necrosis and clostridial enteritis in chickens.

Etiology

Clostridium perfringens and Necrotic Enteritis

Clostridium perfringens is a Gram positive, spore forming, anaerobic rod that is a normal inhabitant of the chicken intestinal tract [3, 7]. Pathogenic strains produce potent extracellular toxins. Historically, alpha toxin (phospholipase C) was considered the primary virulence factor, but subsequent research identified NetB (necrotic enteritis beta like toxin) as the key toxin responsible for the non haemorrhagic form of NE [1, 7]. Strains harboring the netB gene are classified as C. perfringens type G [1]. The bacterium also produces other toxins such as beta2 toxin and enterotoxin, though their roles in avian disease are less defined [2, 8].

Clostridium colinum and Ulcerative Enteritis

Clostridium colinum is a distinct clostridial species that causes ulcerative enteritis, also known as quail disease, in chickens, turkeys, and game birds [9, 10]. This bacterium is fastidious and difficult to isolate, which historically led to underdiagnosis [10]. C. colinum produces a soluble antigen that can be detected by immunofluorescence, but its specific toxin(s) remain incompletely characterized [9, 2].

Epidemiology

Necrotic enteritis occurs worldwide in broiler flocks, with incidence rates varying from less than 1% to over 40% in untreated challenged flocks [5, 11]. The disease is most commonly observed in birds aged 2 to 6 weeks, coinciding with the peak growth phase [3, 4]. Subclinical NE is even more prevalent and manifests as growth depression and impaired feed conversion without overt mortality [3, 12]. Risk factors for NE include coccidiosis, dietary composition (high protein, wheat or barley based diets), immunosuppression, and environmental stress [13, 14, 8]. Coccidial infection caused by Eimeria species damages the intestinal mucosa, providing a predisposing environment for C. perfringens proliferation [14, 7, 15].

Ulcerative enteritis is less frequently reported but occurs sporadically in broilers, layers, and backyard flocks [10]. The disease is often associated with stress, overcrowding, and poor sanitation [2]. C. colinum is transmitted via the fecal oral route and can persist in the environment through spore formation [9, 10].

Clinical Signs

Necrotic Enteritis

Clinical NE presents in two distinct forms: a non haemorrhagic form associated with NetB positive C. perfringens type G and a necro haemorrhagic form that may involve other toxin profiles [1]. The acute form is characterized by sudden onset of depression, ruffled feathers, diarrhea, and wet litter [3, 8]. Mortality can reach 10% to 50% in untreated outbreaks [5, 13]. The subclinical form presents with no overt signs but results in reduced weight gain, increased feed conversion ratio, and uneven flock growth [3, 4].

Ulcerative Enteritis (Quail Disease)

Clinical signs of UE include lethargy, anorexia, watery or bloody diarrhea, and dehydration [9, 10]. Mortality is often high, particularly in young birds. The disease can run a peracute course, and birds may die without premonitory signs [2].

Pathology

Gross Lesions in Necrotic Enteritis

The hallmark lesion of NE is a thickened, friable intestinal mucosa covered by a yellow green to brown diphtheritic membrane (the "Turkish towel" appearance) [1, 8]. Lesions are most prominent in the jejunum and ileum, occasionally extending to the ceca [7]. In the necro haemorrhagic form, the intestinal lumen contains bloody exudate, and the mucosa appears hemorrhagic [1]. The liver and spleen may be congested [14].

Gross Lesions in Ulcerative Enteritis

UE is characterized by multiple, discrete, raised ulcers on the intestinal mucosa, particularly in the duodenum and jejunum [9, 10]. These ulcers are often crateriform with a yellowish center and hyperemic border. Focal necrosis may also occur in the liver, spleen, and heart [2].

Histopathology

Histological examination of NE reveals severe coagulative necrosis of the villi, fibrin deposition, and massive infiltration of heterophils and macrophages [1, 7]. Loss of the epithelial barrier and exposure of the lamina propria are consistent findings. In UE, the ulcers extend into the submucosa and are surrounded by inflammatory cell infiltrates and bacterial colonies [10, 2].

Pathogenesis

The pathogenesis of NE is multifactorial and requires predisposing conditions. Mucosal damage, most commonly caused by coccidiosis (e.g., Eimeria maxima), allows C. perfringens to adhere and proliferate [14, 7, 15]. Alterations in the intestinal microbiota, particularly a reduction in beneficial commensals like Lactobacillus spp., favor clostridial overgrowth [12, 16]. NetB toxin forms pores in host cell membranes, inducing oncosis and necrosis of enterocytes [1, 7]. Alpha toxin contributes to tissue destruction and hemolysis [3].

Mucin gene expression is altered during NE. Infection with Eimeria spp. and C. perfringens reduces expression of MUC2 and MUC13, compromising the protective mucus layer [15]. Conversely, MUC5ac expression is upregulated, likely as a compensatory response [15]. Biofilm formation by C. perfringens further enhances persistence in the gut environment [16].

In UE, the precise mechanism of ulceration is unknown, but it is presumed to involve toxin mediated damage to the intestinal epithelium similar to other clostridial enterotoxemias [9, 2].

flowchart TD
    A[Predisposing factors: Coccidiosis, high-protein diet, immunosuppression], > B[Mucosal damage and dysbiosis]
    B, > C[Clostridium perfringens proliferation]
    C, > D{NetB toxin production}
    D, > E[Pore formation in enterocytes]
    E, > F[Necrosis and inflammation]
    F, > G[Clinical signs: diarrhea, mortality, growth depression]
    G, > H[Diagnosis: pathology, PCR, culture]
    H, > I[Treatment: antimicrobials, alternatives]
    I, > J[Control: biosecurity, vaccination, probiotics]

Diagnostics

Accurate diagnosis of clostridial enteritis requires a combination of clinical, pathological, and microbiological methods [2, 4]. Necropsy with visualization of characteristic gross lesions is often the first step [1, 8].

Bacteriological Culture

C. perfringens can be isolated from intestinal scrapings or liver lesions on selective media (e.g., neomycin blood agar) under anaerobic conditions [11, 17]. Identification is confirmed by Gram staining, colony morphology, and biochemical tests [2]. Isolation of C. colinum is more difficult due to its fastidious growth requirements and the presence of competing flora [10].

Molecular Detection

PCR assays targeting the netB gene are used to identify toxigenic C. perfringens type G strains [1, 2]. Multiplex PCR can simultaneously detect alpha toxin, beta2 toxin, and enterotoxin genes [7, 8]. For C. colinum, a species specific PCR has been developed and shows higher sensitivity than culture [10].

Histopathology and Immunohistochemistry

Histological examination of formalin fixed intestinal sections is definitive for both NE and UE [1, 10]. Immunohistochemistry using antibodies against C. perfringens toxins or C. colinum antigens can confirm the etiology [9, 2].

Acute Phase Protein Assays

Recent work demonstrated that fecal acute phase proteins, such as alpha 1 acid glycoprotein, can serve as non invasive biomarkers for NE in broilers [18].

Antimicrobial Susceptibility Testing

Given rising antimicrobial resistance, susceptibility testing of C. perfringens isolates is recommended to guide therapy. Studies from Canada and Egypt have documented resistance to tetracyclines, macrolides, and lincosamides [19, 17].

Differential Diagnosis

Clostridial enteritis must be distinguished from other enteric diseases such as coccidiosis (see Avian Coccidiosis in Chickens: Prevention, Life Cycle, and Cross-Species Risks), salmonellosis (see Bacterial Pathogens in Chickens: Salmonella, E. coli, and Other Avian Bacteria), and colibacillosis. Eimeria infection often coexists with NE, complicating diagnosis [14, 6]. Clinical history, lesion distribution, and laboratory testing are essential for differentiation [2, 8].

Treatment

Antimicrobial Therapy

Therapeutic options for NE include bacitracin methylene disalicylate, lincomycin, and tylosin, administered via feed or water [20, 2]. However, antimicrobial resistance is increasingly reported [19, 17]. In cases of UE, oxytetracycline or penicillin derivatives are commonly used, although controlled efficacy data in chickens are limited [2].

Alternative Strategies

Due to restrictions on antibiotic growth promoters, alternative interventions are under investigation. Probiotics based on competitive exclusion cultures (e.g., mucosal starter culture) reduce NE incidence and severity in experimental models [5]. Essential oils such as Lippia origanoides and thymol inhibit C. perfringens growth and biofilm formation in vitro and reduce lesion scores in vivo [13, 16]. Oxidized beta carotene (OxC beta) added to feed significantly decreases intestinal lesion scores and clostridial counts in broilers [21]. Bacteriophage therapy has shown promise in reducing mortality and improving gut health in challenged birds [22]. Dietary supplementation with Artemisia extracts modulates immune gene expression and reduces NE severity [23].

Control and Prevention

Control of clostridial enteritis relies on integrated management practices.

Biosecurity

Strict sanitation, litter management, and reduced stocking density minimize environmental contamination with clostridial spores [2, 4]. All in all out production systems break the cycle of infection.

Coccidiosis Control

Because coccidiosis is a major predisposing factor for NE, effective anticoccidial programs are essential. Vaccination with live Eimeria oocysts and strategic use of ionophore anticoccidials (where permitted) help maintain mucosal integrity [6, 14]. The phase out of ionophores in some regions has been associated with shifts in Eimeria and C. perfringens dynamics [6].

Nutritional Management

Dietary manipulations that reduce intestinal viscosity and protein fermentation can limit C. perfringens proliferation [8, 4]. Inclusion of exogenous enzymes, organic acids, and medium chain fatty acids may be beneficial [3, 13].

Vaccination

Vaccines targeting NetB toxin or whole cell C. perfringens antigens are under development but are not yet widely commercialized [1, 7]. Autogenous vaccines are used in some high risk flocks.

Chicken Necrosis

The term "chicken necrosis" in the context of clostridial enteritis refers specifically to the coagulative necrosis of the small intestinal mucosa driven by C. perfringens toxins [1, 7]. This necrosis is the pathological hallmark of NE and differentiates it from other enteritides. The severity of necrosis correlates with toxin load and the extent of predisposing mucosal damage [3, 15]. In the non haemorrhagic form, necrosis is superficial and limited to the villi, whereas in the necro haemorrhagic form, necrosis extends deeper into the submucosa with associated hemorrhage [1]. Subclinical necrosis leads to chronic villous atrophy and malabsorption, explaining the growth depression observed in affected flocks [3, 12]. Understanding the mechanistic basis of necrosis has driven the development of targeted interventions, including toxin neutralizing strategies and anti inflammatory compounds [13, 21, 23].

Conclusion

Avian necrosis and clostridial enteritis in chickens remain significant challenges to global poultry health. The disease complex includes NetB mediated necrotic enteritis and the less common but severe ulcerative enteritis caused by C. colinum. Accurate diagnosis relies on necropsy, histopathology, and molecular detection of toxin genes. Treatment options are constrained by antimicrobial resistance, but alternatives such as probiotics, essential oils, and bacteriophages show promise. Integrated control programs addressing coccidiosis, nutrition, and biosecurity are essential to reduce the burden of these diseases. Continued research into virulence mechanisms, host responses, and novel interventions will be critical for sustainable poultry production.

References

[1] Goossens E, Dierick E, Ducatelle R, et al. Spotlight on avian pathology: untangling contradictory disease descriptions of necrotic enteritis and necro-haemorrhagic enteritis in broilers. Avian Pathology. 2020. https://www.semanticscholar.org/paper/795fed32e8c46bde3d1acb178080dac99249b172

[2] Cooper KK, Songer J, Uzal F. Diagnosing clostridial enteric disease in poultry. Journal of Veterinary Diagnostic Investigation. 2013. https://www.semanticscholar.org/paper/55c02cf7a39d14ddcfce5c8adec7778926237c2d

[3] Priadi A, Natalia L. Clostridial necrotic enteritis in chicken associated with growth rate depression. Jurnal Ilmu Ternak dan Veteriner. 2013. https://www.semanticscholar.org/paper/650c0600b2b01d26085cbf1d9f44987341d96473

[4] Tamirat B, Tamirat H, Bassazin G, et al. Review on necrotic enteritis. Journal. 2017. https://www.semanticscholar.org/paper/db1b4059ef9efb042cbcd7e77308c5c94fd0eeae

[5] Natalia L, Priadi A. Utilization of probiotics for controlling clostridial necrotic enteritis in broiler chickens. Jurnal Ilmu Ternak dan Veteriner. 2012. https://www.semanticscholar.org/paper/4080fcec432406bf98c57ecb51d9ed0eea54a1cc

[6] Estensmo EL, Granstad S, Stevens KB, et al. A new era of coccidiosis control: Eimeria and Clostridium perfringens dynamics in vaccinated broiler flocks after the ionophore phase-out in Norway. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41558264/

[7] Cooper KK. Necrotic enteritis in broiler chickens: studies in disease reproduction and pathogenesis. Journal. 2007. https://www.semanticscholar.org/paper/777ad7d329cb2db6f0834a38817a71e5aff8a511

[8] Wilson J, Tice G, Brash M, et al. Manifestations of Clostridium perfringens and related bacterial enteritides in broiler chickens. Journal. 2005. https://www.semanticscholar.org/paper/bc9d809c735bcc4a89272fac1123aec0ee7be420

[9] Berkhoff GA. Ulcerative enteritis-clostridial antigens. American Journal of Veterinary Research. 1975. https://www.semanticscholar.org/paper/877fa5a153e54504a488313807c6547f484dd730

[10] Bano L, Drigo I, Bacchin C, et al. Application of a PCR method for the diagnosis of ulcerative enteritis: preliminary results. Journal. 2009. https://www.semanticscholar.org/paper/204fd44d32c553b1402b892d0d7680177bbeeac4

[11] Salah-Eldin A, Fawzy E, Aboelmagd BA, et al. Clinical and laboratory studies on chicken isolates of Clostridium perfringens in El-Behera, Egypt. J. World's Poult. Res. 2015. https://www.semanticscholar.org/paper/d2f3f186060fc5eeda1d6aa36731522d95524eb8

[12] Feng Y, Gong J, Yu H, et al. Identification of changes in the composition of ileal bacterial microbiota of broiler chickens infected with Clostridium perfringens. Veterinary Microbiology. 2010. https://www.semanticscholar.org/paper/a27e0e695311de3f02b4a8952a9fb10b2503fe9a

[13] Coles M, Forga A, Señas-Cuesta R, et al. Assessment of Lippia origanoides essential oils in a Salmonella typhimurium, Eimeria maxima, and Clostridium perfringens challenge model to induce necrotic enteritis in broiler chickens. Animals. 2021. https://www.semanticscholar.org/paper/3c2ed976f915d20ee09396899cfd699596114798

[14] Ai Di-yu. Diagnosis and treatment of necrotic enteritis and coccidiosis co-infection in Roman powder laying hens. Journal. 2015. https://www.semanticscholar.org/paper/6707e7c9181c322c851121d8e2a006406dd03adf

[15] Forder R, Nattrass G, Geier M, et al. Quantitative analyses of genes associated with mucin synthesis of broiler chickens with induced necrotic enteritis. Poultry Science. 2012. https://www.semanticscholar.org/paper/0f791c36be4506dc3be14ac93ba1b07d5fdee371

[16] Bhattrai S, Sun Z, Jenkins M, et al. Biofilm formation by clinical Clostridium perfringens isolates and its suppression by thymol. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41605060/

[17] Elkenany R, Elsayed M, Zakaria A, et al. Epidemiology of potential source, risk attribution of Clostridium perfringens from Egyptian broiler farms and genetic diversity of multidrug resistance strains. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/40764721/

[18] Mahmoud MA, Buiatte V, Baumrucker CR, et al. Investigating acute-phase proteins in feces of broiler chickens undergoing necrotic enteritis: a potential tool for assessment and monitoring. Avian Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41973007/

[19] Reedman C, Charlebois A, Hill S, et al. Assessing the associations between antimicrobial use and antimicrobial susceptibility testing results in Clostridium perfringens in Canadian broiler chickens, turkeys, and layer chickens from 2018 to 2023. Anaerobe. 2026. https://pubmed.ncbi.nlm.nih.gov/41587720/

[20] Pengendalian. Pengendalian Clostridial Necrotic Enteritis pada Ayam Pedaging. Journal. 1998. https://www.semanticscholar.org/paper/d484e974501f607f3a5f9d98559d23781cf634e2

[21] Kang M, Oh JY, Cha S, et al. Efficacy of polymers from spontaneous carotenoid oxidation in reducing necrotic enteritis in broilers. Poultry Science. 2018. https://www.semanticscholar.org/paper/265c4a7bb0b489d8ece9d89c051775055bfdbc5c

[22] Muneeb M, Khan EU, Saima, et al. Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis. Res Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40680360/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[23] El-Demerdash A, Mohamady S, Megahed H, et al. Evaluation of gene expression related to immunity, apoptosis, and gut integrity that underlies Artemisia's therapeutic effects in necrotic enteritis-challenged broilers. 3 Biotech. 2023. https://www.semanticscholar.org/paper/3e389ca73cab03f03c4f83c5f46c5c048e7d9638

[24] Karunakaran N, Nagarajan K, Prathiba A, et al. Incidence, diagnosis and treatment of clostridial enteritis in lories and lorikeets. Journal. 2018. https://www.semanticscholar.org/paper/2fec9fb57d5901335c56e056d8f1fe7a34af46c7

[25] O'Toole D. Book review: Clostridial Diseases of Animals. Journal of Veterinary Diagnostic Investigation. 2016. https://www.semanticscholar.org/paper/f2940418f16e513f606303b6b09584a0516b947b